Sex differences in U50,488H-induced phosphorylation of p44/42 mitogen-activated protein kinase in the guinea pig brain

Neuroscience

Volumn 223, Issue , 2012, Pages 447-456

  Rasakham, K ^a,b   McGillivray, K L ^a   Liu Chen, L Y ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Guinea pig; Kappa opioid receptor; Neural activity; P44 42 MAP kinase; Sex difference

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NORBINALTORPHIMINE;

ADULT ANIMAL; AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BRAIN; BRAIN REGION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG SENSITIVITY; EMOTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GUINEA PIG; HABITUATION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMUNOHISTOCHEMISTRY; MALE; NERVOUS SYSTEM; NEURAL ACTIVITY; NONHUMAN; ORBITAL CORTEX; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE DRUG DOSE; THALAMUS;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANIMALS; BRAIN; BRAIN MAPPING; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUINEA PIGS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; SEX CHARACTERISTICS;

EID: 84866482476     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.07.040     Document Type: Article

References (67)

1. Arita J., Porter J.C. Relationship between dopamine release into hypophysial portal blood and prolactin release after morphine treatment in rats. Neuroendocrinology 1984, 38:62-67.
2. Bangasser D.A., Curtis A., Reyes B.A., Bethea T.T., Parastatidis I., Ischiropoulos H., Van Bockstaele E.J., Valentino R.J. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 2010, 15:896-904.
3. Beck K.D., Luine V.N. Sex differences in behavioral and neurochemical profiles after chronic stress: role of housing conditions. Physiol Behav 2002, 75:661-673.
4. Bohn L.M., Belcheva M.M., Coscia C.J. Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade. J Neurochem 2000, 74:564-573.
5. Bot G., Chahl L.A. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain. Brain Res 1996, 731:45-56.
6. Bruchas M.R., Land B.B., Lemos J.C., Chavkin C. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PLoS One 2009, 4:e8528.
7. Butelman E.R., Mandau M., Tidgewell K., Prisinzano T.E., Yuferov V., Kreek M.J. Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans. J Pharmacol Exp Ther 2007, 320:300-306.
8. Calogero A.E., Scaccianoce S., Burrello N., Nicolai R., Muscolo L.A., Kling M.A., Angelucci L., D'Agata R. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro. J Neuroendocrinol 1996, 8:579-585.
9. Carlezon W.A., Beguin C., Dinieri J.A., Baumann M.H., Richards M.R., Todtenkopf M.S., Rothman R.B., Ma Z., Lee D.Y., Cohen B.M. Depressive-like effects of the {kappa}-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 2006, 316:440-447.
10. Carr G.V., Lucki I. Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats. Psychopharmacology (Berl) 2010, 210:295-302.
11. Chang S.L., Squinto S.P., Harlan R.E. Morphine activation of c-fos expression in rat brain. Biochem Biophys Res Comm 1988, 157:698-704.
12. Chen X., Geller E.B., Rogers T.J., Adler M.W. The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats. Brain Res 2007, 1153:52-57.
13. Craft R.M. Sex differences in opioid analgesia: "from mouse to man" Clin J Pain 2003, 19:175-186.
14. Craft R.M., Bernal S.A. Sex differences in opioid antinociception: kappa and 'mixed action' agonists. Drug Alcohol Depend 2001, 63:215-228.
15. Craft R.M., Kruzich P.J., Boyer J.S., Harding J.W., Hanesworth J.M. Sex differences in discriminative stimulus and diuretic effects of the kappa opioid agonist U69,593 in the rat. Pharmacol Biochem Behav 1998, 61:395-403.
16. Craft R.M., McNiel D.M. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats. Pharmacol Biochem Behav 2003, 75:235-245.
17. Craft R.M., Ulibarri C.M., Raub D.J. Kappa opioid-induced diuresis in female vs. male rats. Pharmacol Biochem Behav 2000, 65:53-59.
18. Eitan S., Bryant C.D., Saliminejad N., Yang Y.C., Vojdani E., Keith D., Polakiewicz R., Evans C.J. Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J Neurosci 2003, 23:8360-8369.
19. Elliott J.C., Picker M.J., Sparrow A.J., Lysle D.T. Dissociation between sex differences in the immunological, behavioral, and physiological effects of kappa- and delta-opioids in Fischer rats. Psychopharmacology (Berl) 2006, 185:66-75.
20. Gear R.W., Gordon N.C., Heller P.H., Paul S., Miaskowski C., Levine J.D. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett 1996, 205:207-209.
21. Gear R.W., Miaskowski C., Gordon N.C., Paul S.M., Heller P.H., Levine J.D. Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med 1996, 2:1248-1250.
22. Gershengorn M.C. Mechanism of thyrotropin releasing hormone stimulation of pituitary hormone secretion. Annu Rev Physiol 1986, 48:515-526.
23. Gioiosa L., Chen X., Watkins R., Umeda E.A., Arnold A.P. Sex chromosome complement affects nociception and analgesia in newborn mice. J Pain 2008, 9:962-969.
24. Hooker J.M., Patel V., Kothari S., Schiffer W.K. Metabolic changes in the rodent brain after acute administration of salvinorin A. Mol Imaging Biol 2009, 11:137-143.
25. Hoover W.B., Vertes R.P. Projections of the medial orbital and ventral orbital cortex in the rat. J Comp Neurol 2011, 519:3766-3801.
26. Kanarek R.B., Mandillo S., Wiatr C. Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats. Brain Res 2001, 920:97-105.
27. Kiss J.Z., Kanyicska B., Nagy G.Y. The hypothalamic paraventricular nucleus has a pivotal role in regulation of prolactin release in lactating rats. Endocrinology 1986, 119:870-873.
28. Knoll A.T., Meloni E.G., Thomas J.B., Carroll F.I., Carlezon W.A. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 2007, 323:838-845.
29. Knoll A.T., Muschamp J.W., Sillivan S.E., Ferguson D., Dietz D.M., Meloni E.G., Carroll F.I., Nestler E.J., Konradi C., Carlezon W.A. Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol Psychiatry 2011, 70:425-433.
30. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 1992, 13:177-184.
31. Kreek M.J., Schluger J., Borg L., Gunduz M., Ho A. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions. J Pharmacol Exp Ther 1999, 288:260-269.
32. Land B.B., Bruchas M.R., Schattauer S., Giardino W.J., Aita M., Messinger D., Hnasko T.S., Palmiter R.D., Chavkin C. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci U S A 2009, 106:19168-19173.
33. Laorden M.L., Castells M.T., Martinez M.D., Martinez P.J., Milanes M.V. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus. Endocrinology 2000, 141:1366-1376.
34. Laorden M.L., Castells M.T., Milanes M.V. Effects of U-50488H and U-50488H withdrawal on c-fos expression in the rat paraventricular nucleus. Correlation with c-fos in brainstem catecholaminergic neurons. Br JPharmacol 2003, 138:1544-1552.
35. Li C., Pleil K.E., Stamatakis A.M., Busan S., Vong L., Lowell B.B., Stuber G.D., Kash T.L. Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling. Biol Psychiatry 2012, 71:725-732.
36. Li J.-G., Luo L.Y., Krupnick J.G., Benovic J.L., Liu-Chen L.-Y. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. J Biol Chem 1999, 274:12087-12094.
37. Lilley K.G., Epping R.J., Hafner L.M. The guinea pig estrous cycle: correlation of vaginal impedance measurements with vaginal cytologic findings. Lab Anim Sci 1997, 47:632-637.
38. Liu J., Nickolenko J., Sharp F.R. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A 1994, 91:8537-8541.
39. Liu-Chen L.-Y. Agonist-induced regulation and trafficking of kappa opioid receptors. Life Sci 2004, 75:511-536.
40. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci 1988, 11:308-314.
41. Manzanares J., Wagner E.J., Moore K.E., Lookingland K.J. Kappa opioid receptor-mediated regulation of prolactin and alpha-melanocyte-stimulating hormone secretion in male and female rats. Life Sci 1993, 53:795-801.
42. McLaughlin J.P., Land B.B., Li S., Pintar J.E., Chavkin C. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology 2006, 31:787-794.
43. McLaughlin J.P., Marton-Popovici M., Chavkin C. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 2003, 23:5674-5683.
44. Mezey E., Kiss J.Z. Vasoactive intestinal peptide-containing neurons in the paraventricular nucleus may participate in regulating prolactin secretion. Proc Natl Acad Sci U S A 1985, 82:245-247.
45. Mitsushima D., Yamada K., Takase K., Funabashi T., Kimura F. Sex differences in the basolateral amygdala: the extracellular levels of serotonin and dopamine, and their responses to restraint stress in rats. Eur J Neurosci 2006, 24:3245-3254.
46. Nemeth C.L., Paine T.A., Rittiner J.E., Beguin C., Carroll F.I., Roth B.L., Cohen B.M., Carlezon W.A. Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats. Psychopharmacology (Berl) 2010, 210:263-274.
47. Paine T.A., Tomasiewicz H.C., Zhang K., Carlezon W.A. Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats. Biol Psychiatry 2007, 62:687-693.
48. Pascoe J.E., Williams K.L., Mukhopadhyay P., Rice K.C., Woods J.H., Ko M.C. Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys. Psychoneuroendocrinology 2008, 33:478-486.
49. Paxinos G., Watson C. The rat brain stereotaxic atlas 1998, Academic Press.
50. Pearson G., Robinson F., Beers G.T., Xu B.E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001, 22:153-183.
51. Pfeiffer A., Brantl V., Herz A., Emrich H.M. Psychotomimesis mediated by kappa opiate receptors. Science 1986, 233:774-776.
52. Pugsley M.K., Saint D.A., Walker M.J. An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H. Eur J Pharmacol 1994, 261:303-309.
53. Quirion R., Pilapil C. Distribution of multiple opioid receptors in the human brain. Receptors in the human nervous system 1991, 103-121. Academic Press, Inc., San Diego, CA. F.A.O. Mendelsohn, G. Paxinos (Eds.).
54. Quirion R., Pilapil C., Magnan J. Localization of kappa opioid receptor binding sites in human forebrain using [3H]U69,593: comparison with [3H]bremazocine. Cell Mol Neurobiol 1987, 7:303-307.
55. Rasakham K., Liu-Chen L.Y. Sex differences in kappa opioid pharmacology. Life Sci 2011, 88:2-16.
56. Roberson E.D., English J.D., Adams J.P., Selcher J.C., Kondratick C., Sweatt J.D. The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J Neurosci 1999, 19:4337-4348.
57. Shannon H.E., Eberle E.L., Mitch C.H., McKinzie D.L., Statnick M.A. Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats. Neuropharmacology 2007, 53:930-941.
58. Sharp T., Zetterstrom T., Ljungberg T., Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res 1987, 401:322-330.
59. Shippenberg T.S., Zapata A., Chefer V.I. Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 2007, 116:306-321.
60. Shuster S.J., Riedl M., Li X., Vulchanova L., Elde R. The kappa opioid receptor and dynorphin co-localize in vasopressin magnocellular neurosecretory neurons in guinea-pig hypothalamus. Neuroscience 2000, 96:373-383.
61. Taylor C.C., Wu D., Soong Y., Yee J.S., Szeto H.H. Kappa-opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor. J Pharmacol Exp Ther 1996, 277:877-884.
62. Taylor T., Wondisford F.E., Blaine T., Weintraub B.D. The paraventricular nucleus of the hypothalamus has a major role in thyroid hormone feedback regulation of thyrotropin synthesis and secretion. Endocrinology 1990, 126:317-324.
63. Tindal J.S. The forebrain of the guinea pig in stereotaxic coordinates. J Comp Neurol 1965, 124:259-266.
64. Valjent E., Pages C., Herve D., Girault J.A., Caboche J. Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 2004, 19:1826-1836.
65. von Voigtlander P.F., Lahti R.A., Ludens J.H. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. J Pharmacol Exp Ther 1983, 224:7-12.
66. Waddell J., Bangasser D.A., Shors T.J. The basolateral nucleus of the amygdala is necessary to induce the opposing effects of stressful experience on learning in males and females. J Neurosci 2008, 28:5290-5294.
67. Wang Y.J., Rasakham K., Huang P., Chudnovskaya D., Cowan A., Liu-Chen L.Y. Sex difference in {kappa}-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig. J Pharmacol Exp Ther 2011, 339:438-450.